Skip to main content
. 2025 May 12;17(5):1148–1163. doi: 10.18632/aging.206247

Table 3. Multivariate logistic regression models for frailty worsening 1 year later.

Crude OR aOR* 95% CI-OR** Sig
Sex
 Male Reference Reference
 Female 1.03 1.18 1.13–1.20 <.001
Age groups
 65–74 years Reference Reference
 75–84 years 1.62 1.72 1.65–1.79 <.001
 85+ years 2.56 2.80 2.63–2.98 <.001
SES groups
 Low Reference Reference
 Intermediate 0.91 0.91 0.87–0.95 <.001
 High 0.80 0.77 0.72–0.82 <.001
Sector
 Jewish secular Reference Reference
 Jewish orthodox 0.95 0.91 0.86–0.96 <.001
 Arabic 1.21 1.11 1.04–1.19 <.001
MEFI 2023
 Fit Reference Reference
 Mild frailty 1.12 0.57 0.54–0.60 <.001
 Moderate frailty 1.51 0.45 0.42–0.48 <.001
 Severe frailty 0.74 0.12 0.10–0.13 <.001
Hosp. year before
 No Reference Reference
 Yes 1.52 1.41 1.35–1.48 <.001
CCI groups
 0 Reference Reference
 1–2 1.62 1.74 1.66–1.83 <.001
 3–5 2.01 2.57 2.42–2.73 <.001
 6+ 2.52 4.01 3.68–4.37 <.001
BMI groups
 Underweight 1.61 0.56 0.50–0.64 <.001
 Normal weight Reference Reference
 Overweight 0.96 0.53 0.47–0.60 0.42
 Obesity 1.06 0.58 0.51–0.66 <.001
Comorbidity
 Act. Limitation 0.34 0.33 0.25–0.43 <.001
 Atrial Fibrillation 1.58 1.59 1.51–1.68 <.001
 Dementia 2.03 1.734 1.63–1.86 <.001
 Fall Related 0.63 0.61 0.54–0.69 <.001
 Heart Failure 1.74 1.60 1.51–1.70 <.001
 Housebound 2.00 1.83 1.71–1.97 <.001
 Hypertension 1.68 1.66 1.58–1.74 <.001
 Kidney disease 1.54 1.39 1.32–1.47 <.001
 Memory/Cognitive 1.73 2.23 2.13–2.33 <.001
 Polypharmacy 2.75 2.87 2.63–3.13 <.001
 Require for Care 0.10 0.05 0.02–0.13 <.001
 Sleep disturbance 0.29 0.33 0.27–0.41 <.001

*aOR, odds ratio adjusted for other listed variables. **All the aOR were significant at p < 0.001.